Hologic: Hologic, Inc. to Showcase AI-Powered Breast Imaging Advancements Designed to Assess Breast Density, Enhance Workflows and Improve Cancer Detection

Hologic, Inc. will reveal new technologies reimagining the future of breast health at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago on December 1-5, 2024. On the show floor and during multiple workshops, Hologic will showcase AI-powered breast imaging advancements designed to assess breast density, enhance workflows and improve cancer detection. For the first time, attendees can experience the cutting-edge Envision Mammography Platform, which offers patients a high-speed Hologic 3D mammogram with an 2.5-second scan time. This next-generation technology provides a more comfortable exam with tilt positioning, adapting to patients rather than the other way around. As the first FDA-approved mammography technology of its kind, the Envision platform enhances the detection of subtle objects, minimizes focal spot blur and improves 3D image sharpness. Further demonstrating its leadership in breast imaging AI, Hologic will also introduce its next-generation Genius AI Detection 2.0 solution for use in the United States. This advanced cancer screening technology expands on Hologic's Genius AI detection 2.0 solution by providing even greater accuracy and efficiency, giving radiologists more confidence and helping to reduce false positives. This new mammography AI assistant provides: A deep-learning 2D and 3D algorithm that improves specificity by using a patient's prior exam in the current exam's analysis. Intuitive 1-10 case and lesion scoring and pre-populated exam reports designed to accelerate image review and save radiologists' valuable time. An all-in-one interface that conveniently includes deep-learning breast densityscoring along with key patient and mammogram quality information, designed to support radiologists at every step of the reading workflow. On December 1 at RSNA, Hologic will also present the results of a recently published study demonstrating the performance of its Genius AI Detection 2.0 software across diverse patient populations. The study looked at more than 7,500 3D mammograms from women who identified as Asian, Black, Hispanic or white. Researchers found that the measured performance of the algorithm was similar across all cohorts evaluated, illustrating its ability to deliver results that are not impacted by racial bias. Reducing racial bias in AI algorithms is a growing concern in healthcare. In the South Hall, Booth #1919 at McCormick Place, attendees can experience Hologic?s Dimensions mammography portfolio, Envision Mammography Platform, Genius AI Detection 2.0 and Genius AI Detection PRO software, Affirm Contrast Biopsy software, I-View Contrast Enhanced Mammography software and a full suite of breast biopsy and surgery solutions. The company will also showcase recently acquired Endomag wireless breast surgery localization and lymphatic tracing solutions, including the Magseed marker, the Magtrace lymphatic tracer and the Sentimag platform.